Yan Shi, MD

Education

School Education Degree Year
University of Maryland – College Park Bachelors Bachelor of Science 2007
University of Arkansas for Medical Sciences Internship Doctor of Medicine 2011
Baylor College of Medicine Residency General Surgery 2018
Hofstra University Fellowship Pediatric Surgery 2020

Personal Statement

Dr. Yan Shi is an assistant professor in the Division of Pediatric Surgery. His clinical interests include pediatric surgical oncology, thoracic wall deformities (Nuss procedure), congenital malformations, pilonidal disease, lung lesions and minimally invasive surgery. An avid researcher, Dr. Shi has written several academic papers on topics relating to pediatric malignant tumors, oncology surgery and treatment of solid pediatric tumors. He has also published several noteworthy studies related to the treatment of malignant tumors in children.

Dr. Shi is board certified by the American Board of Surgery in Pediatric Surgery and General Surgery.


Clinical and Research Interests

  • Chest wall reconstruction/Pectus
  • Minimally invasive surgery
  • Pilonidal disease
  • Surgical quality and outcomes


Organizations

  • American Academy of Pediatrics - Fellow
  • American College of Surgeons - Fellow
  • American Pediatric Surgery Association - Member, Education Committee
  • Operating Room Product and Equipment Committee/Texas Children's Hospital - Member
  • Surgical Quality Committee/Texas Children’s Hospital - Member


Selected Publications

Shi Y, Kvasnovsky C, Khan S, Jain S, Sargeant D, Lamoshi A, Prince J, Sathya C. Impact of the COVID-19 pandemic on trauma activations at a pediatric level 1 trauma center in New York. Pediatric Surgery International. 2021 Oct;37(10):1409-1414. doi: 10.1007/s00383-021-04962-7. Epub 2021 Jul 15. PubMed PMID: 34264357; PubMed Central PMCID: PMC8280274.

Woodfield SE, Shi Y, Patel RH, Chen Z, Shah AP, Srivastava RK, Whitlock RS, Ibarra AM, Larson SR, Sarabia SF, Badachhape A, Starosolski Z, Ghaghada KB, Sumazin P, Annis DA, López-Terrada D, Vasudevan SA. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Scientific Reports. 2021 Feb 3;11(1):2967. doi: 10.1038/s41598-021-82542-4. PubMed PMID: 33536467; PubMed Central PMCID: PMC7859402.

Shi Y, Commander SJ, Masand PM, Heczey A, Goss JA, Vasudevan SA. Vascular invasion is a prognostic indicator in hepatoblastoma. Journal of Pediatric Surgery. 2017 Jun;52(6):956-961. doi: 10.1016/j.jpedsurg.2017.03.017. Epub 2017 Mar 16. PubMed PMID: 28347528.

Shi Y, Rojas Y, Zhang W, Beierle EA, Doski JJ, Goldfarb M, Goldin AB, Gow KW, Langer M, Meyers RL, Nuchtern JG, Vasudevan SA. Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer Database. Pediatric Blood and Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26272. Epub 2016 Oct 26. PubMed PMID: 27781381; PubMed Central PMCID: PMC5333454.

Shi Y, Geller JI, Ma IT, Chavan RS, Masand PM, Towbin AJ, Chintagumpala M, Nuchtern JG, Tiao GM, Thompson PA, Vasudevan SA. Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy. Journal of Pediatric Surgery. 2016 Apr;51(4):525-9. doi: 10.1016/j.jpedsurg.2015.10.053. Epub 2015 Oct 24. PubMed PMID: 26607968.

Shi Y, Ma IT, Patel RH, Shang X, Chen Z, Zhao Y, Cheng J, Fan Y, Rojas Y, Barbieri E, Chen Z, Yu Y, Jin J, Kim ES, Shohet JM, Vasudevan SA, Yang J. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis. Cell Death Disease. 2015 Aug 6;6:e1841. doi: 10.1038/cddis.2015.207. PubMed PMID: 26247726; PubMed Central PMCID: PMC4558500.

Shi Y, Felsted AE, Masand PM, Mothner BA, Nuchtern JG, Rodriguez JR, Vasudevan SA. Congenital left paraduodenal hernia causing chronic abdominal pain and abdominal catastrophe. Pediatrics. 2015 Apr;135(4):e1067-71. doi: 10.1542/peds.2014-3701. PubMed PMID: 25802350.

View PubMed Publications

View Google Scholar Publications